First Time Loading...

ReproCell Inc
TSE:4978

Watchlist Manager
ReproCell Inc Logo
ReproCell Inc
TSE:4978
Watchlist
Price: 135 JPY -0.74% Market Closed
Updated: Apr 29, 2024

ReproCell Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ReproCell Inc
Operating Income Peer Comparison

Comparables:
2160
4587
4974
J
7774
S
4599

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
ReproCell Inc
TSE:4978
Operating Income
-¥438.3m
CAGR 3-Years
27%
CAGR 5-Years
27%
CAGR 10-Years
-21%
GNI Group Ltd
TSE:2160
Operating Income
¥5.2B
CAGR 3-Years
44%
CAGR 5-Years
55%
CAGR 10-Years
N/A
PeptiDream Inc
TSE:4587
Operating Income
¥6.8B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Takara Bio Inc
TSE:4974
Operating Income
¥1.5B
CAGR 3-Years
-49%
CAGR 5-Years
-21%
CAGR 10-Years
-2%
J
Japan Tissue Engineering Co Ltd
TSE:7774
Operating Income
-¥155.3m
CAGR 3-Years
18%
CAGR 5-Years
17%
CAGR 10-Years
17%
S
StemRIM Inc
TSE:4599
Operating Income
¥142.4m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ReproCell Inc's Operating Income?
Operating Income
-438.3m JPY

Based on the financial report for Dec 31, 2023, ReproCell Inc's Operating Income amounts to -438.3m JPY.

What is ReproCell Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-21%

Over the last year, the Operating Income growth was -12%. The average annual Operating Income growth rates for ReproCell Inc have been 27% over the past three years , 27% over the past five years , and -21% over the past ten years .